Turkey’s Ministry of Interior denied rumors about the suspension of the issuance of a residence permit in Istanbul, Tesla launched the first serial Cybertruck four years after the presentation, and Russia entered India’s top three trade partners for the first time. . These and other news of the day are in the RB summary.

Issuance of a residence permit in Istanbul, agreement Pfizer and Seagen, the first Cybertruck: highlights of July 16

World

  • Turkey’s Ministry of the Interior denied media reports about the suspension of the issuance of a residence permit in Istanbul. The ministry reminded that the restriction is valid only in 10 districts.

  • The EU is investigating a $43 billion acquisition of biotech company Seagen by Pfizer.

  • For the first time, Russia entered India’s top three largest trading partners: in the first five months of 2023, trade between the countries grew 3.8 times, reaching a record $27.1 billion.

  • Countering Russian attempts to circumvent US sanctions is one of the US Treasury’s key tasks for 2023, Treasury Secretary Janet Yellen said.

Business

  • Twitter continues to operate at a loss due to falling ad revenue despite the reduction. In one of his responses, Elon Musk mentioned that the company “needs to get into cash flow positive.”

  • Tesla has announced that it has assembled the first production Cybertruck pickup four years after the prototype was unveiled.

Photo: Yavuz Meyveci / Shutterstock

Author:

Ahmed Sadulayev

Source: RB

Previous articleThis dishwasher doesn’t care how you load your dishesHome Appliance12:30 | 16 July 2023
Next articleEuropeans blocked access to a new social network: VPN doesn’t helpAdditions12:45 | 16 July 2023
I am a professional journalist and content creator with extensive experience writing for news websites. I currently work as an author at Gadget Onus, where I specialize in covering hot news topics. My written pieces have been published on some of the biggest media outlets around the world, including The Guardian and BBC News.

LEAVE A REPLY

Please enter your comment!
Please enter your name here